StockData

Meta Platforms vs Microsoft

META and MSFT side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How META and MSFT compare

Microsoft is the larger company, worth 2.5 times as much as Meta Platforms ($3.9T against $1.6T).

On earnings, Meta Platforms is cheaper: it trades at 23.2× trailing earnings, against 29.1× for Microsoft.

Meta Platforms grew revenue faster over the last twelve months (27.7% versus 17.8% for Microsoft).

Microsoft keeps more of each dollar of sales as profit, with a net margin of 40.3% compared with 29.8% at Meta Platforms.

Both pay dividends: Meta Platforms yields 0.34% and Microsoft 0.70%.

Microsoft scores higher on the StockData Score (22 against 19 for Meta Platforms), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMETAMSFT
Size and price
Market cap$1.6T$3.9T
Share price$614.99$521.91
Change, 1 year−18.2%−3.6%
Change, 5 years80.3%55.3%
Beta (5Y)1.391.14
Employees79K223K
StockData Score
Total score1922 (better)
Valuation score4 (better)2
Growth score34 (better)
Performance score56 (better)
Health score46 (better)
Dividend score34 (better)
Valuation
P/E23.2× (better)29.1×
P/S6.9× (better)11.7×
P/B6.0× (better)8.8×
EV/EBITDA14.2× (better)24.7×
P/FCF38.2× (better)57.9×
PEG0.58 (better)1.27
FCF yield2.6% (better)1.7%
Fair value$649.84$510.33
Margin of safety5.4% (better)−2.3%
Growth
Revenue growth (TTM)27.7% (better)17.8%
Revenue growth, 5Y average18.5% (better)14.6%
Net income growth (TTM)−4.8%31.3% (better)
EPS growth (TTM)−3.7%31.6% (better)
EPS growth, 5Y average18.4% (better)17.4%
Profitability
Gross margin81.7% (better)67.9%
Operating margin38.1%46.8% (better)
Net margin29.8%40.3% (better)
FCF margin18.0%20.2% (better)
Return on equity29.8%34.0% (better)
Return on invested capital31.4%35.9% (better)
Financial health
Debt / equity0.320.09 (better)
Net debt / EBITDA−0.06−0.24
Interest coverage–50.9×
Current ratio2.23 (better)1.23
Altman Z-score6.809.14 (better)
Piotroski F-score66
Dividends and buybacks
Dividend yield0.34%0.70% (better)
Payout ratio7.9%19.8%
Years of dividend growth116 (better)
Dividend growth, 5Y average–10.2%
Buyback yield0.21%0.52% (better)
Shareholder yield0.55%1.2% (better)
Ownership
Held by institutions66.9%74.1%
Held by insiders13.5%0.04%
Insider net buying, 12 months−$256M−$113M (better)
Superinvestors holding25 (better)21
Short interest, % of float1.5%0.82%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.